A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined Inclusion/Exclusion Criteria apply.
Fayetteville, Arkansas 72703, United States
Fort Gratiot, Michigan 48059, United States
Albuquerque, New Mexico 87131, United States
Buenos Aires, C1425BEN, Argentina
Vienna, 01130, Austria
Nantes, 44093, France
Catania, 95123, Italy
Naples, 80131, Italy
Amsterdam, 1105 AZ, Netherlands
Bialystok, 15-453, Poland